Daily Versus Alternate Day Regimen of Iron Supplementation in Children with Iron Deficiency Anemia

The goal of this clinical trial is to learn if giving iron supplementation every other day is as effective as giving it daily in children with Iron Deficiency Anemia. The main questions it aims to answer are: 1. Will alternate day regimen improve hemoglobin and iron profile just as well as daily dose? 2. Which group will suffer less side effects from Iron Supplementation? Participants will be divided into two groups: Group A: will receive oral Iron supplementation daily for 2 months Group B: will receive oral Iron supplementation every other day for 2 months Participants will be monitored using weekly phone calls to insure compliance and report side effects. Both groups will be given Albendazole 400 mg once at the beginning of the study to be repeated in 1 week

NCT Number	NCT06631612
Lead Sponsor	Ain Shams University
Conditions	Iron Deficiency Anemia Treatment
Enrollment	72 participants
Start Date	2024-01-01
Primary Completion	2025-01 (estimated)
Study Completion	2025-03 (estimated)
Updated on ClinicalTrials.gov	2024-10-08